CompletedNot Applicable

Multisystemic Therapy-Emerging Adults Trial

United States193 participantsStarted 2016-09-01

Plain-language summary

This study's purpose is to test the effectiveness of a promising intervention for emerging adults (EAs) with mental illness (MI) and serious antisocial behavior in achieving the ultimate outcome of reduced antisocial behavior, and proximal intermediate outcomes. Multisystemic Therapy-Emerging Adults (MST-EA) is an adaptation of MST, a well-established, effective intervention for antisocial behavior in adolescents.

Who can participate

Age range16 Years – 26 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * age 16-26 * recent arrest or release from jail/prison/detention (within the past 18 months but excluding arrests for probation/parole violations) * presence of mood, anxiety, and/or psychotic disorders * able to reside in a stable community setting (not currently homeless, not currently inpatient; can include individual ready for discharge to the community) * subject consent Exclusion Criteria: * actively psychotic, suicidal, or homicidal * Pervasive Developmental Disorders (PDD) or mental retardation * sex offending as the primary antisocial behavior * adults unable to consent will also be excluded from this study

What they're measuring

Change in number and severity of criminal charges in official records in the 16 months pre-baseline compared with the 16 months post-baseline.

Timeframe: 16 months pre-baseline compared with 16 months post-baseline

Trial details

NCT IDNCT02922335

SponsorUniversity of Massachusetts, Worcester

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-09-01

View on ClinicalTrials.gov More Antisocial Behavior trials